Literature DB >> 17983597

The polyglutamine-expanded protein ataxin-3 decreases bcl-2 mRNA stability.

Chih-Liang Tien1, Feng-Chen Wen, Mingli Hsieh.   

Abstract

Machado-Joseph disease/Spinocerebellar ataxia type 3 is an autosomal dominant neurodegenerative disease caused by polyglutamine-expanded ataxin-3. In this study, COS7-MJD26-GFP and COS7-MJD78-GFP cells, which were stably transfected with GFP-tagged full-length MJD gene with either 26 or 78 glutamine repeat, were used to demonstrate that both protein and mRNA levels of bcl-2 are decreased in the presence of expanded ataxin-3. However, the promoter activity in COS7-MJD78-GFP cells is much higher than that in COS7-MJD26-GFP, suggesting that the decrease of bcl-2 expression may be due to defects in mRNA stability. Therefore, 5,6-dichloro-benzimidazole 1-beta-D-ribofuranoside, an adenosine analogue to inhibit mRNA synthesis, was used to estimate the bcl-2 mRNA degradation rate. Our results demonstrated that bcl-2 mRNA decay in COS7-MJD78-GFP cells is about 3.5-fold faster than that in COS7-MJD26-GFP. Our study provides evidence, for the first time, that dysfunction of mRNA stability resulted from the presence of mutant ataxin-3.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17983597     DOI: 10.1016/j.bbrc.2007.10.162

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Current understanding on the pathogenesis of polyglutamine diseases.

Authors:  Xiao-Hui He; Fang Lin; Zheng-Hong Qin
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

2.  Bcl-2 Decreases the Affinity of SQSTM1/p62 to Poly-Ubiquitin Chains and Suppresses the Aggregation of Misfolded Protein in Neurodegenerative Disease.

Authors:  Liang Zhou; Hongfeng Wang; Haigang Ren; Qingsong Hu; Zheng Ying; Guanghui Wang
Journal:  Mol Neurobiol       Date:  2014-10-14       Impact factor: 5.590

3.  Treatment with Caffeic Acid and Resveratrol Alleviates Oxidative Stress Induced Neurotoxicity in Cell and Drosophila Models of Spinocerebellar Ataxia Type3.

Authors:  Yu-Ling Wu; Jui-Chih Chang; Wei-Yong Lin; Chien-Chun Li; Mingli Hsieh; Haw-Wen Chen; Tsu-Shing Wang; Chin-San Liu; Kai-Li Liu
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

4.  An elongated tract of polyQ in the carboxyl‑terminus of human α1A calcium channel induces cell apoptosis by nuclear translocation.

Authors:  Ji Sun; Xiguang Sun; Zhuo Li; Dihui Ma; Yudan Lv
Journal:  Oncol Rep       Date:  2020-04-22       Impact factor: 3.906

5.  In Vitro Efficacy and Molecular Mechanism of Curcumin Analog in Pathological Regulation of Spinocerebellar Ataxia Type 3.

Authors:  Yu-Ling Wu; Jui-Chih Chang; Yi-Chun Chao; Hardy Chan; Mingli Hsieh; Chin-San Liu
Journal:  Antioxidants (Basel)       Date:  2022-07-18

Review 6.  From pathways to targets: understanding the mechanisms behind polyglutamine disease.

Authors:  Jonasz Jeremiasz Weber; Anna Sergeevna Sowa; Tina Binder; Jeannette Hübener
Journal:  Biomed Res Int       Date:  2014-09-21       Impact factor: 3.411

7.  Far-infrared radiation protects viability in a cell model of Spinocerebellar Ataxia by preventing polyQ protein accumulation and improving mitochondrial function.

Authors:  Jui-Chih Chang; Shey-Lin Wu; Fredrik Hoel; Yu-Shan Cheng; Ko-Hung Liu; Mingli Hsieh; August Hoel; Karl Johan Tronstad; Kuo-Chia Yan; Ching-Liang Hsieh; Wei-Yong Lin; Shou-Jen Kuo; Shih-Li Su; Chin-San Liu
Journal:  Sci Rep       Date:  2016-07-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.